Ultragenyx Pharmaceutical Vs. Perspective Therapeutics Industry Stock Comparison

Sell

47

RARE
Ultragenyx Pharmaceutical

Last Price:

54.79

Seasonality Move:

12.42%

Sell

30

CATX
Perspective Therapeutics

Last Price:

11.88

Seasonality Move:

19.45%

Sell

47

Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

The current Ultragenyx Pharmaceutical [RARE] share price is $54.69. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

30

Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

The current Perspective Therapeutics [CATX] share price is $11.69. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

The Ultragenyx Pharmaceutical share price today is $54.69
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

The Perspective Therapeutics share price today is $11.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.03	Sell
Relative Strength Index (14 RSI):	46.74	Sell
Chaikin Money Flow:	-417236	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(53.89 - 57.39)	Sell
Bollinger Bands (100):	(42.72 - 56.34)	Buy

CATX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.36	Sell
Relative Strength Index (14 RSI):	37.83	Sell
Chaikin Money Flow:	-513230	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(12.33 - 13.27)	Sell
Bollinger Bands (100):	(11.35 - 14.45)	Sell

RARE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	55.79	Sell
20-day SMA:	55.04	Sell
50-day SMA:	55.76	Sell
200-day SMA:	47.58	Buy
8-day EMA:	55.24	Sell
20-day EMA:	55.36	Sell
50-day EMA:	54.2	Buy
200-day EMA:	48.52	Buy

CATX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	12.49	Sell
20-day SMA:	12.77	Sell
50-day SMA:	13.81	Sell
200-day SMA:	12.33	Sell
8-day EMA:	12.47	Sell
20-day EMA:	12.84	Sell
50-day EMA:	13.21	Sell
200-day EMA:	11.76	Sell

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.

Ultragenyx Pharmaceutical Technical Analysis

	Oct 9	Oct 10	Oct 11	Oct 14	Oct 15	Oct 16	Oct 18	Oct 21	Oct 22	Oct 23
	Oct
	09	10	11	14	15	16	18	21	22	23
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

	Oct 9	Oct 10	Oct 11	Oct 14	Oct 15	Oct 16	Oct 18	Oct 21	Oct 22	Oct 23
	Oct
	09	10	11	14	15	16	18	21	22	23
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):